In accordance with the results of our previous study [11], we also found that MYDGF can improve glucose-lipid metabolism and IR in NAFLD, and that these positive effects can contribute to the protective effects of MYDGF in the context of NAFLD. Here, MYDGF is linked to metabolic dysfunction-associated steatotic liver disease.